Milton Park

Enigma Announces the Start of US Clinical Trials for Its Influenza A/B Detection Assay

Older News

MILTON PARK, OXFORD, England and SAN DIEGO, April 11, 2011 - Enigma Diagnostics announced today that it has commenced clinical trials for its intended point of care Enigma(R) ML Influenza A/B detection assay.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy